5th Circ. Told To Undo Sanofi's Win In Chemo Hair Loss Row
A patient who alleges Sanofi failed to warn its chemotherapy drug Taxotere carried a risk of permanent hair loss told the Fifth Circuit that her doctor's testimony should have precluded the...To view the full article, register now.
Already a subscriber? Click here to view full article